A Journey Around Boronic Acids: Sulfonyl Hydrazone‐Containing Derivatives as Carbonic Anhydrase Inhibitors
Chemical Biology & Drug Design · 2025
DOI: 10.1111/cbdd.70108 ↗At a glance
Journal article in Chemical Biology & Drug Design, 2025. Written by Deniz A Anakök and 11 co-authors. Institution: Department of Chemistry, Faculty of Science, Gazi University, Ankara, Turkey. Major MEDLINE topics: Carbonic Anhydrase Inhibitors, Boronic Acids, Hydrazones. Cited 2 times so far (Crossref); 73 references. Funded by: Associazione Italiana per la Ricerca sul Cancro, TUBITAK, Consorzio Interuniversitario Biotecnologie.
Abstract (original language)
Recently, a rising interest in boronic acids and their derivatives was recorded in the Medicinal Chemistry field due to their high versatility and broad applicability as bioactive compounds in several diseases, including cancer and microbial infections. The ability of boronic acid moieties to bind zinc ions was first hypothesized by the inhibitory activity of bortezomib, a boron‐containing protease inhibitor, on different isoforms of the Carbonic Anhydrase (CA, EC: 4.2.1.1) enzyme family and then assessed through X‐ray crystallographic studies on benzoxaboroles in complex with hCA II. These findings, along with the overexpression of isoforms IX and XII in hypoxic cancer and, in particular, breast cancer, drove us to explore the chemical space around the phenylboronic acids by generating a focused library of 16 derivatives (1–4a–d) decorated with alkyl sulfonyl hydrazones. The compounds were then subjected to stopped flow‐based inhibition assays on a panel of hCAs, including the tumor‐associated isoforms, revealing low micromolar inhibition constants ( K I s) in some cases. However, antiproliferative assays conducted on a human triple‐negative breast cancer cell line showed a lack of activity at the tested concentrations.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Chemistry, Faculty of Science, Gazi University, Ankara, Turkey.
- NEUROFARBA Department, Pharmaceutical and Nutraceutical Section, University of Florence, Florence, Italy.
- Department of Pharmacy, University of Pisa, Pisa, Italy.
- Department of Pharmacy, "G. D'annunzio" University of Chieti-Pescara, Chieti, Italy.
- Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
- Department of Biology, Agriculture and Food Sciences, National Research Council (CNR), Institute of Biosciences and Bioresources, Naples, Italy.
ORCID profiles: Andrea Angeli, Ilaria D'Agostino, Gioele Renzi, Maria Luisa Massardi, Camilla Tavani, Simone Carradori, Roberto Ronca, Clemente Capasso, Fabrizio Carta, Claudiu T Supuran
Funding
- Associazione Italiana per la Ricerca sul Cancro
- TUBITAK
- Consorzio Interuniversitario Biotecnologie
- Fondazione AIRC per la ricerca sul cancro ETS
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
Cite
APA
Anakök, D. A., Angeli, A., D'Agostino, I., Renzi, G., Massardi, M. L., Tavani, C., Çete, S., Carradori, S., Ronca, R., Capasso, C., Carta, F., & Supuran, C. T. (2025). A Journey Around Boronic Acids: Sulfonyl Hydrazone‐Containing Derivatives as Carbonic Anhydrase Inhibitors. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70108
Vancouver
Anakök DA, Angeli A, D'Agostino I, Renzi G, Massardi ML, Tavani C, et al. A Journey Around Boronic Acids: Sulfonyl Hydrazone‐Containing Derivatives as Carbonic Anhydrase Inhibitors. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70108
BibTeX
@article{Anakk2025,
author = {Anakök, Deniz A and Angeli, Andrea and D'Agostino, Ilaria and Renzi, Gioele and Massardi, Maria Luisa and Tavani, Camilla and Çete, Servet and Carradori, Simone and Ronca, Roberto and Capasso, Clemente and Carta, Fabrizio and Supuran, Claudiu T},
title = {A Journey Around Boronic Acids: Sulfonyl Hydrazone‐Containing Derivatives as Carbonic Anhydrase Inhibitors},
journal = {Chemical Biology & Drug Design},
year = {2025},
doi = {10.1111/cbdd.70108}
}
EUVIMED